Literature DB >> 3800351

Noninvasive and quantitative 19F nuclear magnetic resonance study of flucytosine metabolism in Candida strains.

J P Vialaneix, N Chouini, M C Malet-Martino, R Martino, G Michel, J P Lepargneur.   

Abstract

19F nuclear magnetic resonance was used for a noninvasive and quantitative study of flucytosine (FC; 5-fluorocytosine) metabolism in two strains of Candida albicans and one strain of Candida tropicalis with various susceptibilities to FC. Three intracellular fluorinated metabolites were detected in the highly susceptible strain, F-nucleotides (Fnt), F-nucleosides, and 5-fluorouracil (5FU). Fnt were partially converted into 5FU when the spectra of the yeasts were recorded at 37 degrees C without perfusion, but the intensities of the signals were not modified at 4 or 37 degrees C if the cells were perfused. In the acid extract, the Fnt signal was resolved into three distinct peaks; none of them was attributable to 5-fluoro-2'-deoxyuridine-5'-monophosphate. The same signals were detected in the partially resistant strain, but only 5FU was observed in the highly resistant strain; the resistance of the latter strain therefore was primarily due to a defect in UMP pyrophosphorylase. At the end of the incubation period, only FC and released 5FU were present in the culture media. The concentration of the intracellular fluorinated metabolites was increased if the strain was susceptible to FC. The total amount of metabolized FC was very similar for the highly susceptible and the partially resistant strains, but the percentage of Fnt was much higher in the former (38%) than in the latter (8%); the mild resistance of the partially resistant strain therefore was attributed to the decreased activity of UMP pyrophosphorylase.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3800351      PMCID: PMC176527          DOI: 10.1128/AAC.30.5.756

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Mode of action of 5-fluorocytosine.

Authors:  R B Diasio; J E Bennett; C E Myers
Journal:  Biochem Pharmacol       Date:  1978-03-01       Impact factor: 5.858

2.  Mode of action of 5-fluorocytosine and mechanisms of resistance.

Authors:  A Polak; H J Scholer
Journal:  Chemotherapy       Date:  1975       Impact factor: 2.544

3.  In vivo 19F-NMR of 5-fluorouracil incorporation into RNA and metabolites in Escherichia coli cells.

Authors:  M Gochin; T L James; R H Shafer
Journal:  Biochim Biophys Acta       Date:  1984-05-22

4.  A 19F nuclear magnetic resonance study of uptake and metabolism of 5-fluorocytosine in susceptible and resistant strains of Candida albicans.

Authors:  M Di Vito; F Podo; A Torosantucci; G Carpinelli; W L Whelan; D Kerridge; A Cassone
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

5.  Genetic and physiological aspects of resistance to 5-fluoropyrimidines in Saccharomyces cerevisiae.

Authors:  R Jund; F Lacroute
Journal:  J Bacteriol       Date:  1970-06       Impact factor: 3.490

6.  New approach to metabolism of 5'-deoxy-5-fluorouridine in humans with fluorine-19 NMR.

Authors:  M C Malet-Martino; R Martino; A Lopez; J P Béteille; M Bon; J Bernadou; J P Armand
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

7.  Studies on the mode of action of 5-fluorocytosine in Aspergillus species.

Authors:  G E Wagner; S Shadomy
Journal:  Chemotherapy       Date:  1979       Impact factor: 2.544

8.  Isolation and characterization of two 5-fluorouracil-substituted Escherichia coli initiator methionine transfer ribonucleic acids.

Authors:  D C Hills; M L Cotten; J Horowitz
Journal:  Biochemistry       Date:  1983-03-01       Impact factor: 3.162

9.  Mechanisms of action of 5-fluorocytosine.

Authors:  A R Waldorf; A Polak
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

10.  5-fluorouracil metabolism monitored in vivo by 19F NMR.

Authors:  A N Stevens; P G Morris; R A Iles; P W Sheldon; J R Griffiths
Journal:  Br J Cancer       Date:  1984-07       Impact factor: 7.640

View more
  8 in total

1.  F Nuclear Magnetic Resonance Analysis of 5-Fluorouracil Metabolism in Four Differently Pigmented Strains of Nectria haematococca.

Authors:  D Parisot; M C Malet-Martino; R Martino; P Crasnier
Journal:  Appl Environ Microbiol       Date:  1991-12       Impact factor: 4.792

2.  Kinetic analysis of hyaluronidase activity using a bioactive MRI contrast agent.

Authors:  Liora Shiftan; Michal Neeman
Journal:  Contrast Media Mol Imaging       Date:  2006 May-Jun       Impact factor: 3.161

3.  Study of the metabolism of flucytosine in Aspergillus species by 19F nuclear magnetic resonance spectroscopy.

Authors:  N Chouini-Lalanne; M C Malet-Martino; R Martino; G Michel
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

4.  Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy.

Authors:  L D Stegman; A Rehemtulla; B Beattie; E Kievit; T S Lawrence; R G Blasberg; J G Tjuvajev; B D Ross
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

5.  Monitoring beta-lactamase activity in vivo by 13C nuclear magnetic resonance spectroscopy.

Authors:  S Mobashery; S A Lerner; M Johnston
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

6.  19F nuclear magnetic resonance analysis of 5-fluorouracil metabolism in wild-type and 5-fluorouracil-resistant Nectria haematococca.

Authors:  D Parisot; M C Malet-Martino; P Crasnier; R Martino
Journal:  Appl Environ Microbiol       Date:  1989-10       Impact factor: 4.792

7.  19F nuclear magnetic resonance study of fluoropyrimidine metabolism in strains of Candida glabrata with specific defects in pyrimidine metabolism.

Authors:  M O Fasoli; D Kerridge; P G Morris; A Torosantucci
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

8.  Enhanced 5-fluorouracil cytotoxicity and elevated 5-fluoronucleotides in the rat Walker carcinosarcoma following methotrexate pre-treatment: a 19F-MRS study in vivo.

Authors:  P M McSheehy; M J Prior; J R Griffiths
Journal:  Br J Cancer       Date:  1992-03       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.